Apollo Gleneagles Hospitals Organizes Two-day International Conference on Frontotemporal Dementia in Asia
Apollo Gleneagles Hospitals, Kolkata, the pioneer of cutting-edge healthcare solutions in Eastern India, is the acknowledged leader for the dissemination of advanced medical knowledge. Strengthening this robust tradition, the Hospital has organized a two-day International Conference on Frontotemporal Dementia in Asia.
The event, scheduled for January 14 and 15, 2017, will see a panel of distinguished neurologists from some of the best institutes and hospitals across the world and the country converge for an engaging discussion on the emerging trends and the on-ground reality in the diagnosis and management of Frontotemporal Dementia, whose proportion of patients with a positive family history in Asian cohorts range from 9.5% to 27%. Dr Amitabha Ghosh, Director, Department of Neurology, Apollo Gleneagles Hospitals, Kolkata, and organizing chairperson of the conference, said, "Frontotemporal dementia is the second most common cause of dementia under the age of 65 in many cohorts, after Alzheimer's disease. By striking at a relatively young ages, the disease leads to huge economic and social burden on the patient, the family and to society as a whole. While much research has been undertaken in western countries, emerging Asian data over the last several years have consistently shown distinctive clinical and genetic patterns in Asian patients. Our conference, with faculty from leading institutes in the USA, Singapore, Taiwan, Philippines and Japan, and from the major facilities in India, seeks to highlight the Asian contribution to the understanding of this very challenging dementia, and to discuss and share the latest knowledge in the domain to help improve the overall understanding the condition."
Dr Rupali Basu, President and CEO ER, Apollo Hospitals Group, India, observed, "Neurological disorders like dementia are often mistakenly attributed to the signs of an advanced age. This leads to a significant lacuna in the overall reporting and management, causing several of our near and dear ones to spend their days in considerable discomfort. As the healthcare leader of the region, we have always taken a key role in addressing the multiple health challenges faced by the people, and this conference is an effort to change the overall paradigm of the treatment and management of Frontotemporal dementia. We will continue to organize more such programmes to help drive the overall transformation of the healthcare scenario for the benefit of the people."